Chemed (CHE) Misses Q3 EPS by 3c, Offers Guidance
Tweet
Share
E-mailGet Alerts CHE Hot Sheet
Price: $444.11 +1.84%
Revenue Growth %: +7.6%
Financial Fact:
Income from operations: 42.87M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Revenue Growth %: +7.6%
Financial Fact:
Income from operations: 42.87M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Chemed (NYSE: CHE) reported Q3 EPS of $1.48, $0.03 worse than the analyst estimate of $1.51. Revenue for the quarter came in at $358.4 million versus the consensus estimate of $360 million.
Chemed sees FY2014 EPS of $6.00-$6.05, versus the consensus of $5.95.
For earnings history and earnings-related data on Chemed (CHE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance
- FedEx (FDX) Tops Q4 EPS by 39c, Beats on Revenue; Offers FY27 EPS Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
